Purchase Order HHSN269201400642P

Award Date 6/12/14
Potential Completion Date 6/11/15
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77267, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a $240,120.00 firm fixed price purchase order to Onco Inc., a woman-owned small business, to provide oncology cancer registry software, support, and maintenance. The contract was set aside for small businesses and has a completion date of October 31, 2024. Onco Inc. has provided similar oncology-focused software, IT services, data management, and analytical support to other federal health agencies such as the Defense...
This is a $2,949,902 definitive, firm fixed-price federal contract awarded by the Food and Drug Administration (FDA) to Mckesson Specialty Health Pharmaceutical & Biotech Solutions LLC, a subsidiary of Mckesson Corporation, to leverage real-world data to investigate the natural history of rare cancers treated in the U.S. community oncology setting. The contract has an ultimate completion date of September 29, 2028. This award was made under the FDA's Broad Agency Announcement for research...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to procure existing clinical and treatment data on at least 500 pediatric cancer patients treated with photon therapy since 2007. The contract, valued at $97,021.21, is part of the NCI's Cancer Genome Atlas (TCGA) program and will support the U.S. Pediatric Photon Therapy Comparison...
This is a $23,000.00 firm fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 to Dayton Clinical Oncology Program, Inc., a non-profit organization that provides cancer research services. The contract is for oncology subscription services with a period of performance ending on May 31, 2029. This appears to be an annual renewal of a contract that has been in place since at least 2019, facilitating...
<p>This federal contract award is for ONCOLOGY SERVICES, valued at $210,740.50, and was awarded by the Veterans Integrated Service Network 23 (VISN 23), a civilian agency, to The Whitaker Companies Inc., a for-profit limited liability company. The contract has a firm fixed price pricing type and a delivery order contract type, with a period of performance ending on June 19, 2010. There is no set-aside designation indicated for this award.</p>
This firm-fixed price purchase order for $241,990 was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to The Trustees of Columbia University in the City of New York. The contract supports large-scale data analysis to characterize variations in cancer treatments across the United States to assist the NCI's Division of Cancer Control and Population Sciences. The prime contractor, Columbia University, is...
This is a $14,790.00 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract is for the delivery of laboratory supplies to support NCI's cancer research programs, clinical trials, and patient care initiatives. The contract does not have a set-aside designation, indicating open competition. Intera...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 issued a $97,386.93 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Advanced Accelerator Applications USA Inc. for PLUVICTO direct cancer treatment. The firm fixed price order has a completion date of September 30, 2022 under Master Contract FSS-61-IB, with performance in Millburn, New Jersey. No set-aside designation was applied to the award made to the...
This is a $2,160 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 mg/20 mL vials of the chemotherapy drug Oxaliplatin, a critical medical commodity supporting military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract, valued at $826,186.14, is for providing prostate cancer testing services to the VA under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract has an ultimate completion date of June...

US ONCOLOGY, INC.:1239902 [14-012809]

Posted 6/12/14, 12:00 AM